日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements.

Zenocutuzumab 是一种 HER2xHER3 双特异性抗体,可有效治疗由 NRG1 基因重排驱动的肿瘤

Schram Alison M, Odintsov Igor, Espinosa-Cotton Madelyn, Khodos Inna, Sisso Whitney J, Mattar Marissa S, Lui Allan J W, Vojnic Morana, Shameem Sara H, Chauhan Thrusha, Torrisi Jean, Ford Jim, O'Connor Marie N, Geuijen Cecile A W, Schackmann Ron C J, Lammerts van Bueren Jeroen J, Wasserman Ernesto, de Stanchina Elisa, O'Reilly Eileen M, Ladanyi Marc, Drilon Alexander, Somwar Romel

A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma

经典霍奇金淋巴瘤患者对PD-1阻断疗法反应的外周免疫特征

Cader, Fathima Zumla; Hu, Xihao; Goh, Walter L; Wienand, Kirsty; Ouyang, Jing; Mandato, Elisa; Redd, Robert; Lawton, Lee N; Chen, Pei-Hsuan; Weirather, Jason L; Schackmann, Ron C J; Li, Bo; Ma, Wenjiang; Armand, Philippe; Rodig, Scott J; Neuberg, Donna; Liu, X Shirley; Shipp, Margaret A

Mass cytometry of Hodgkin lymphoma reveals a CD4(+) regulatory T-cell-rich and exhausted T-effector microenvironment

霍奇金淋巴瘤的质谱流式细胞术分析显示,其微环境富含CD4(+)调节性T细胞,而效应T细胞则处于耗竭状态。

Cader, Fathima Zumla; Schackmann, Ron C J; Hu, Xihao; Wienand, Kirsty; Redd, Robert; Chapuy, Bjoern; Ouyang, Jing; Paul, Nicole; Gjini, Evisa; Lipschitz, Mikel; Armand, Philippe; Wu, David; Fromm, Jonathan R; Neuberg, Donna; Liu, X Shirley; Rodig, Scott J; Shipp, Margaret A